Loading
institutionsInstitution
Movember
The moustache-growing men's health charity that has become one of the largest global funders of prostate and testicular cancer research.
Also called: Movember Foundation
Overview
Founded in Melbourne in 2003, Movember raises money each November and funds men's health in three areas: prostate cancer, testicular cancer and mental health and suicide prevention. In cancer it funds global collaborations rather than single labs, including the Global Action Plan programmes on biomarkers, active surveillance (GAP3) and precision medicine, the TrueNTH survivorship programmes, the IRONMAN international registry of advanced prostate cancer, and partnerships with the Prostate Cancer Foundation and Prostate Cancer UK. Movember-funded work has supported PSMA theranostics and tests to distinguish aggressive from indolent disease.
Location
Melbourne, AU
Type
consortium
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#362 · 18 points (0 Newsweek + 0 NCI + 18 from 9 linked objects) · ranking
- Global Action Plan (GAP) research collaborations
- IRONMAN registry
- TrueNTH survivorship
- PCF-Movember partnership
Andrew Little
Chief Executive Officer, Movember
Charity leadershipMen's healthProstate and testicular cancer funding
Chief Executive of Movember, the global men's health charity that funds prostate cancer, testicular cancer and mental health programmes.
Michael Hofman
Professor of Nuclear Medicine; Director, Prostate Cancer Theranostics and Imaging Centre of Excellence
TheranosticsPSMA PETLutetium-PSMA therapy
Led proPSMA and TheraP, the trials that proved PSMA PET beats conventional imaging and that lutetium-PSMA beats chemotherapy.
Similar pages
- TrialproPSMA
Shares Michael Hofman, ANZUP Cancer Trials Group, Peter MacCallum Cancer Centre, PSMA PET.
- PersonShahneen Sandhu
Shares ANZUP Cancer Trials Group, Peter MacCallum Cancer Centre, Radioligand therapy (beta emitters), Prostate cancer.
- PersonDeclan G. Murphy
Shares ANZUP Cancer Trials Group, Peter MacCallum Cancer Centre, PSMA PET, Prostate cancer.
- TrialTheraP (ANZUP 1603)
Shares Michael Hofman, ANZUP Cancer Trials Group, Peter MacCallum Cancer Centre, PSMA PET.
- IdeaA university cyclotron network with shared regulatory files for new tracers
Shares Michael Hofman, Peter MacCallum Cancer Centre, PSMA PET, Radioligand therapy (beta emitters).
- CollectionPROMISE registry: free germline testing in prostate cancer
Shares Prostate Cancer Foundation (PCF), Germline (hereditary) testing, Prostate cancer.
- PersonJeremie Calais
Shares PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.
- PersonJohannes Czernin
Shares PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.